EMN
53
4
T
68
2
SPG
55
4
ZTS
33
2
INTU
71
2
NOC
34
-6
ORCL
71
3
L
55
9
TDC
67
-3
ED
49
4
HRB
60
3
UA
48
-8
AAPL
46
-2
CSCO
74
7
TAP
41
-2
KMI
73
2
AMT
39
2
SLG
57
2
DE
69
4
KSS
49
3
EMN
53
4
T
68
2
SPG
55
4
ZTS
33
2
INTU
71
2
NOC
34
-6
ORCL
71
3
L
55
9
TDC
67
-3
ED
49
4
HRB
60
3
UA
48
-8
AAPL
46
-2
CSCO
74
7
TAP
41
-2
KMI
73
2
AMT
39
2
SLG
57
2
DE
69
4
KSS
49
3
Financhill
Back

iShares US Pharmaceuticals ETF Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
32

IHE
iShares US Pharmaceuticals ETF

Last Price:
$64.67
Seasonality Move:
3.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

iShares US Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 8.6% based on the past 19 years of stock performance.
  • iShares US Pharmaceuticals ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is iShares US Pharmaceuticals ETF Stock Undervalued?
    The current iShares US Pharmaceuticals ETF [IHE] share price is $64.83. The Score for IHE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • IHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will iShares US Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 8.6% based on the past 19 years of stock performance.

iShares US Pharmaceuticals ETF Stock Rating

Sell
32
iShares US Pharmaceuticals ETF (IHE) is a Sell

Is iShares US Pharmaceuticals ETF overpriced?

  • iShares US Pharmaceuticals ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

iShares US Pharmaceuticals ETF Stock Price History

Is IHE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
73.28
52-Week Low:
58.97

Prediction Charts

Market Cap:
0
Price in USD:
64.83
Volume:
100.2K
Beta:
0.70

Technical Analysis

SMA50:
66.48
SMA100:
67.67
SMA200:
68.72
52-Wk Change:
-2.26%

Stock Predictions

  • Is iShares US Pharmaceuticals ETF stock public?
    Yes, iShares US Pharmaceuticals ETF is a publicly traded company.
  • What is the iShares US Pharmaceuticals ETF stock quote today?
    The iShares US Pharmaceuticals ETF stock price is 64.83 USD today.
  • How to buy iShares US Pharmaceuticals ETF stock online?
    You can buy iShares US Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 66.77 67.88 68.17 66.77
Apr-30 67.90 68.14 68.47 67.43
May-1 66.81 65.39 66.81 65.36
May-2 66.84 66.79 66.99 66.31
May-5 66.63 66.47 66.70 66.31
May-6 65.95 64.12 65.95 64.00
May-7 64.47 64.92 65.20 64.47
May-8 64.62 64.70 65.13 64.06
May-9 64.74 63.74 64.94 63.68
May-12 63.69 65.02 65.42 63.69
May-13 64.46 63.62 64.46 63.60
May-14 63.71 62.06 63.90 62.02
May-15 62.59 63.63 63.63 62.42
May-16 63.58 64.83 64.83 63.58

iShares US Pharmaceuticals ETF Earnings

Data Unavailable

iShares US Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* iShares US Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.